COMPERA 2.0:肺动脉高压四层风险分层模型
基于COMPERA欧洲注册研究1655例肺动脉高压患者数据,在原有三层模型基础上将中危细分为中低危和中高危,采用细化的功能分级、6分钟步行距离和BNP/NT-proBNP界值计算诊断时和首次随访时风险。四层模型对预后相关风险变化更敏感,尤其随访评估时对长期生存的预测更细致。
要点
- 三层模型下多数患者归为中危,四层模型可进一步区分中低危与中高危。
- 四层模型对随访时风险变化的识别更敏感,与长期死亡风险变化相关。
- 风险分层基于WHO功能分级、6MWD和BNP/NT-proBNP的细化界值。
核心结论
- 采用功能分级、6MWD和BNP/NT-proBNP细化界值的四层风险分层模型,比原三层模型对预后相关风险变化更敏感。
研究设计与样本
- 分析COMPERA欧洲肺动脉高压注册研究数据,共纳入1655例肺动脉高压患者,计算诊断时和首次随访时的风险。
- 生存分析采用Kaplan-Meier法、log-rank检验和Cox比例风险模型。
主要发现
- 三层模型下,基线时76.0%患者为中危,首次随访时63.9%为中危。
- 四层模型实现了更细致的风险区分,尤其随访评估时能预测长期生存。
- 从基线到随访,三层模型31.1%患者风险类别发生变化,四层模型为49.2%。
- 包括中低危与中高危之间的风险变化,均与长期死亡风险变化相关。
关键数值与推荐
- 风险分层基于WHO功能分级、6分钟步行距离和血清BNP或NT-proBNP水平,采用细化界值。
- 三层模型将风险分为低、中、高危,基于预期1年死亡率。
- 四层模型将中危细分为中低危和中高危。
临床怎么用
- 对肺动脉高压患者进行风险分层时,可考虑使用四层模型以更敏感地识别预后相关风险变化。
- 随访中应关注风险类别变化,包括中低危与中高危之间的转换,因其与长期死亡风险相关。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND: Risk stratification plays an essential role in the management of patients with pulmonary arterial hypertension (PAH). The current European guidelines propose a three-stratum model to categorise risk as low, intermediate or high, based on the expected 1-year mortality. However, with this model, most patients are categorised as intermediate risk. We investigated a modified approach based on four risk categories, with intermediate risk subdivided into intermediate-low and intermediate-high risk. METHODS: We analysed data from the Comparative, Prospective Registry of Newly Initiated Therapies for Pulmonary Hypertension (COMPERA), a European pulmonary hypertension registry, and calculated risk at diagnosis and first follow-up based on World Health Organization functional class, 6-min walk distance (6MWD) and serum levels of brain natriuretic peptide (BNP) or N-terminal pro-BNP (NT-proBNP), using refined cut-off values. Survival was assessed using Kaplan-Meier analyses, log-rank testing and Cox proportional hazards models. RESULTS: Data from 1655 patients with PAH were analysed. Using the three-stratum model, most patients were classified as intermediate risk (76.0% at baseline and 63.9% at first follow-up). The refined four-stratum risk model yielded a more nuanced separation and predicted long-term survival, especially at follow-up assessment. Changes in risk from baseline to follow-up were observed in 31.1% of the patients with the three-stratum model and in 49.2% with the four-stratum model. These changes, including those between the intermediate-low and intermediate-high strata, were associated with changes in long-term mortality risk. CONCLUSIONS: Modified risk stratification using a four-stratum model based on refined cut-off levels for functional class, 6MWD and BNP/NT-proBNP was more sensitive to prognostically relevant changes in risk than the original three-stratum model.
引用
- Hoeper MM, Pausch C, Olsson KM, et al. COMPERA 2.0: a refined four-stratum risk assessment model for pulmonary arterial hypertension. Eur Respir J. 2022. PMID: 34737226. doi:10.1183/13993003.02311-2021
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。